EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Platelet-Rich Plasma from the Research to the Clinical Arena: A Journey Toward the Precision Regenerative Medicine

Elisabetta Mormone iD, Vittoria D'Esposito iD, Paola De Luca iD, Fulvio E O Ferrara iD, Francesca P Bellotti, Pietro Formisano, Eugenio Caradonna iD

International Journal of Molecular Sciences · 21.01.2026 · 27 (2) · 1058

DOI: 10.3390/ijms27021058 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.01.2026. Verfasst von Elisabetta Mormone und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapies (ISBReMIT), Fondazione IRCCS "Casa Sollievo della Sofferenza", 71013 …. Hauptthemen laut MEDLINE: Platelet-Rich Plasma, Regenerative Medicine, Precision Medicine. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Platelet-rich plasma (PRP) is a cornerstone of regenerative medicine, offering therapeutic potential across numerous clinical disciplines. Its efficacy relies on concentrated platelets and plasma components that release growth factors, cytokines, and extracellular vesicles to orchestrate tissue repair, immunomodulation, and angiogenesis. Recent findings have uncovered novel mechanisms, such as mitochondrial transfer from platelets to target cells and the delivery of bioactive microRNAs that regulate inflammation and metabolic reprogramming. However, despite its potential, PRP therapy is often limited by inconsistent results. In this review, we examine how patient-specific factors—including age, comorbidities, and lifestyle—and technical variables in preparation and storage, influence the biological quality of the final product. Therefore, standardizing protocols and accounting for individual biological variability are essential for achieving reproducible outcomes. In conclusion, PRP is a complex therapeutic agent whose success depends on both intrinsic bioactive content and extrinsic processing factors. Integrating these molecular insights with personalized patient assessment is crucial to optimizing PRP treatment procedures. Future research should focus on refining standardization to fully establish PRP as a precision medicine tool in regenerative therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet-Rich PlasmaRegenerative MedicinePrecision MedicineHumansAnimalsIntercellular Signaling Peptides and Proteins

Stichwörter der Autor:innen

aginganticoagulantblood cellscentrifugationcytokinesdietgrowth factorslaboratory medicinepre-analytical phase

Substanzen

Intercellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapies (ISBReMIT), Fondazione IRCCS "Casa Sollievo della Sofferenza", 71013 San Giovanni Rotondo, Italy.
  • Institute of Endotypes in Oncology, Metabolism and Immunology "G. Salvatore"-National Research Council (IEOMI-CNR), Via Pansini 5, 80131 Naples, Italy.
  • Orthopaedic Biotechnology Lab, IRCCS Ospedale Galeazzi-Sant'Ambrogio, Via Cristina Belgioioso 173, 20157 Milan, Italy.
  • Laboratory Medicine Department, CDI-Centro Diagnostico Italiano, Via Saint Bon 20, 20147 Milan, Italy.
  • Department of Translational Medicine, University of Naples "Federico II", Via Pansini 5, 80131 Naples, Italy.
  • Centro di Nanofotonica e Optoelettronica per la Salute dell'Uomo (CNOS), 82100 Benevento, Italy.

ORCID-Profile: Elisabetta Mormone, Vittoria D'Esposito, Paola De Luca, Fulvio E O Ferrara, Eugenio Caradonna

Zitieren

APA

Mormone, E., D'Esposito, V., De Luca, P., Ferrara, F. E. O., Bellotti, F. P., Formisano, P., & Caradonna, E. (2026). Platelet-Rich Plasma from the Research to the Clinical Arena: A Journey Toward the Precision Regenerative Medicine. International Journal of Molecular Sciences, 27(2), 1058. https://doi.org/10.3390/ijms27021058

Vancouver

Mormone E, D'Esposito V, De Luca P, Ferrara FEO, Bellotti FP, Formisano P, et al. Platelet-Rich Plasma from the Research to the Clinical Arena: A Journey Toward the Precision Regenerative Medicine. International Journal of Molecular Sciences. 2026;27(2):1058. doi:10.3390/ijms27021058

BibTeX
@article{Mormone2026,
  author = {Mormone, Elisabetta and D'Esposito, Vittoria and De Luca, Paola and Ferrara, Fulvio E O and Bellotti, Francesca P and Formisano, Pietro and Caradonna, Eugenio},
  title = {Platelet-Rich Plasma from the Research to the Clinical Arena: A Journey Toward the Precision Regenerative Medicine},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {2},
  pages = {1058},
  doi = {10.3390/ijms27021058}
}
Kostenlos starten →